Abstract：Objective To investigate the clinical effect of autohemotherapy in the treatment of bronchial asthma at remittent period.Methods From May 2015 to May 2017,a total of 120 outpatient and inpatient patients with bronchial asthma during remission period treated in Department of Respiratory of the First Traditional Chinese Medicine Hospital in Changde City were selected and they were divided into the treatment group(n=60)and control group(n=60)according to the random number table method.Patients in the control group were treated with Salmeterol Roticasone Powder,while patients in the treatment group were treated with autohemotherapy via meridians.The efficacy and the asthma control test(ACT)score before and after treatment between the two groups were compared.Results There was no significant difference of the curative effect between the two groups (P＞0.05).There was no significant difference in ACT score between the two groups before treatment,after treatment and follow-up for 1 month (P＞0.05).The ACT score of the two groups after treatment was higher than that before treatment,and the difference was statistically significant(P＜0.05).Follow-up for 1 month showed that ACT scores of the two groups were significantly higher than those before and after treatment,with statistical differences (P＜0.05).Conclusion Both autohemotherapy and Salmeterol Roticasone Powder have curative effect in the treatment of asthma during remission period.There is no significant difference in the efficacy treated by autohemotherapy and Salmeterol Roticasone Powder therapy.
郑远方; 李夏妹; 李斐斐; 胡朝霞. 自血疗法治疗支气管哮喘缓解期的临床效果观察[J]. 中国当代医药, 2019, 26(8): 158-161.
ZHENG Yuan-fang; LI Xia-mei; LI Fei-fei; HU Zhao-xia. Clinical effect observation of autohemotherapy in the treatment of bronchial asthma during remission period. 中国当代医药, 2019, 26(8): 158-161.
京公网安备 11010502046607号